Stay updated on PCSK9 Inhibitors in HoFH Clinical Trial
Sign up to get notified when there's something new on the PCSK9 Inhibitors in HoFH Clinical Trial page.

Latest updates to the PCSK9 Inhibitors in HoFH Clinical Trial page
- CheckyesterdayChange DetectedA banner announces an NIH website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.8%

- Check8 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check15 days agoChange DetectedThe website’s revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check36 days agoChange DetectedA new revision entry v3.7.0 appears in the record history, indicating an updated version of the study record, while the previous revision v3.6.6 has been removed from the history.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision tag v3.6.6 appears in the Record History, replacing the earlier v3.6.5. This signals a minor update to the page metadata for the study record.SummaryDifference0.1%

- Check78 days agoChange DetectedA new revision entry (v3.6.5) was added to the record history, updating the version trail for the study, while the previous revision (v3.6.4) was removed from the history.SummaryDifference0.1%

Stay in the know with updates to PCSK9 Inhibitors in HoFH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PCSK9 Inhibitors in HoFH Clinical Trial page.